Provided by Tiger Trade Technology Pte. Ltd.

ImmunityBio, Inc.

9.80
-0.3200-3.16%
Post-market: 9.840.0399+0.41%17:40 EDT
Volume:11.53M
Turnover:113.32M
Market Cap:10.39B
PE:-9.91
High:10.06
Open:10.00
Low:9.56
Close:10.12
52wk High:12.43
52wk Low:1.95
Shares:1.06B
Float Shares:407.00M
Volume Ratio:0.84
T/O Rate:2.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9887
EPS(LYR):-0.3820
ROE:78.05%
ROA:-30.54%
PB:-9.92
PE(LYR):-25.65

Loading ...

Movement Alert|ImmunityBio, Inc. Falls 5.24% in Regular Trading, trading at $9.57

Market Focus
·
Yesterday

Immunitybio Inc Stock (IBRX) Moved Up by 8.17% on Oct 9: Drivers Behind the Movement

TradingKey
·
Oct 10

ImmunityBio Stock Draws Interest Ahead Of Rare Cancer Data Presentation

Simply Wall St.
·
Oct 09

Movement Alert|ImmunityBio, Inc. Rises 5.05% in Regular Trading, Biotechnology Sector Gains on Broad Strength

Market Focus
·
Oct 09

ImmunityBio Founder Soon-Shiong Joins Piper Sandler Virtual Oncology Symposium Fireside Chat

Reuters
·
Oct 08

ImmunityBio Director Cheryl Cohen Reports Disposal of Common Shares Worth $851,088

Reuters
·
Oct 07

Movement Alert|ImmunityBio, Inc. Falls 5.15% in Regular Trading, Biotechnology Sector Weakens Broadly

Market Focus
·
Oct 06

Movement Alert|ImmunityBio, Inc. Rises 5.69% in Pre-Market Trading, Trading at $10.87

Market Focus
·
Oct 05

Immunitybio Inc Stock (IBRX) Moved Up by 9.64% on Oct 2: What Investors Need To Know

TradingKey
·
Oct 03

ImmunityBio call volume above normal and directionally bullish

TIPRANKS
·
Oct 02

ImmunityBio Attends Thoracic Rare Cancer Symposium Thoracs

Reuters
·
Oct 02

ImmunityBio rises 11.6%

TIPRANKS
·
Oct 02

Movement Alert|ImmunityBio, Inc. Rises 10.13% in Regular Trading, Trading at $10.2101

Market Focus
·
Oct 02

HLS Therapeutics Appoints Linda Maxwell, Mark DeLong as Independent Directors

Reuters
·
Oct 01

Immunitybio Inc Stock (IBRX) Moved Up by 11.15% on Sep 30: What Signal Does It Send?

TradingKey
·
Oct 01

ImmunityBio rises 12.3%

TIPRANKS
·
Oct 01

ImmunityBio’s New Sepsis Trial: Early-Stage Data With High-Stakes Market Potential

TIPRANKS
·
Sep 26

ImmunityBio call volume above normal and directionally bullish

TIPRANKS
·
Sep 23

PDS Biotech Adds Patrick Soon-Shiong, NantBio CFO James Banaag to Board

Reuters
·
Sep 14

PDS Biotech Announces Initial Closing of up to $22.3 Million Pipe Financing and the Appointment of DR. Patrick Soon-Shiong to Its Board of Directors

THOMSON REUTERS
·
Sep 14